MRTX - Mirati Therapeutics GAAP EPS of -$3.51 beats by $0.16 revenue of $0.93M misses by $1.72M February, 28 2023 04:41 PM Mirati Therapeutics Inc. Mirati Therapeutics press release ( NASDAQ: MRTX ): Q4 GAAP EPS of -$3.51 beats by $0.16 . Revenue of $0.93M (+210.0% Y/Y) misses by $1.72M . For further details see: Mirati Therapeutics GAAP EPS of -$3.51 beats by $0.16, revenue of $0.93M misses by $1.72M